Asta Medica, Aktiengesellschaft

Asta-werke Aktiengesellschaft, Chemische Fabrik

Jurij Stekar

Bernhard Kutscher

Peter Hilgard

Jurgen Engel

Wolfgang Schumacher

Gerhard Nossner

Gerhard N&ouml;ssner

J&uuml;rgen Engel

Norbert Brock

A method of treating protozoal and fungal diseases is described, in which an effective amount of a compound of formula I is administered to a host having a protozoal or fungal disease. Also described are methods of treating bone marrow damage composed of administering, to a host having bone marrow damage due to treatment with cytostatic agents or other myelotoxic active ingredients, an effective amount of a compound of formula I

Methods of using therapeutic phospholipid derivatives

Phospholipid derivatives

Phospholipid derivatives containing higher elements of the Vth main group (P, As, Sb, Bi), their method of preparation and antineoplastic and antimicrobially active medications that can be prepared from the phospholipid derivatives.

Phospholipid derivatives containing higher elements of the fifth group

Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphate and a process for its preparation. This compound is useful for the treatment of cancer.

Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphate and a process for its

The invention is related to a process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents administered to them against malign tumors, comprising administering a pharmacologically acceptable salt of a dithiodi-(alkane sulfonic acid) having the general formula ##STR1## to the human treated with the cytostatically active alkylating agent, in an amount ranging from 20% of the weight of the alkylating agent to the highest tolerated dosage of the salt of the dithiodi-(alkane sulfonic acid), simultaneously or separately in combination with the alkylating agent.

Process for the treatment of humans suffering from undesired urotoxic

Growing community of inventors

Bielefeld, Germany

Jurij Stekar